A daily vitamin D supplement could help reduce the symptoms of irritable bowel disease (IBD), a study has found.

A research team led by Sir Run-Run Shaw Hospital, Zhejiang University School of Medicine, has published a comprehensive ...

Spyre Therapeutics, Inc. (NASDAQ: SYRE), a clinical-stage biotechnology company pioneering long-acting antibodies and antibody combinations to redefine the standard of care for inflammatory bowel ...

Older adults with acute severe ulcerative colitis have higher mortality, underscoring the need for targeted strategies to ...

Upadacitinib vs ustekinumab reduced steroid use in TNF-exposed UC, with similar safety and clinical outcomes at 1 year.

Inflammatory bowel disease, often called IBD, is a long-term condition that causes inflammation in the digestive system. It ...

People with inflammatory bowel disease often ask a simple but difficult question: what should I eat? Inflammatory bowel ...

(Nasdaq: EQ), a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders, today announced that new EQ504 preclinical data have been accepted for poster ...

This biotech innovator in antibody therapies for IBD reported a notable insider sale amid ongoing preclinical development ...

A groundbreaking discovery in modernizing traditional Chinese medicine (TCM) has been achieved. A study has, for the first ...

It’s been a little over two months since President Donald Trump’s direct-to-consumer pharmaceutical site, TrumpRx, launched, ...

Nearly one-third of patients with IBD experience moderate-to-severe disability, with higher risk in active disease and Crohn disease.